STAT

Opinion: I’ve unconsciously contributed to the racial gap in infant mortality. Not anymore

Closing the racial gap in infant mortality must become a priority. Clinicians need to make sure that implicit bias doesn't influence the care they deliver.

While I was on call in the neonatal intensive care unit the other day, a baby born prematurely at 24 weeks died in his mother’s arms. Having seen this tragic outcome many times in my career, I reflexively knew what to do next: call the chaplain and the photographer, bring out the memory-making kits, and sign the death certificate.

Without needing to think about it, I listed the cause of death: prematurity. Because I work in a large university hospital in urban Chicago, it is

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks